STAT Plus: Biosimilars got the cold shoulder from health plans when it came to preferred coverage
JEAN-CHRISTOPHE VERHAEGEN/AFP/GETTY IMAGES
“If health plans don’t prioritize coverage for biosimilars, then utilization will never grow," said James Chambers, a Tufts University associate professor.
No hay comentarios:
Publicar un comentario